5 Key Takeaways

• 1

  Primary care initiation of continuous glucose monitoring (CGM) may lead to greater reductions in hemoglobin A1c among insulin-treated diabetes patients.

• 2

  In a study of 8,502 patients, those who initiated CGM saw a 0.66 percentage point decrease in HbA1c at 12 months compared to 0.17 percentage points in non-users.

• 3

  CGM initiation was associated with a 13% lower likelihood of recurrent hospitalizations and an 18% lower likelihood of emergency department visits.

• 4

  Only 28% of eligible patients received a CGM prescription during the study period, despite insurance coverage and clinical eligibility.

• 5

  The study's observational nature limits the ability to infer causation, and findings may not be generalizable to uninsured patients.